References
- Mundy G R, Cove D H, Fisken R. Primary hyperparathyroidism: Changes in the pattern of clinical presentation. Lancet 1980; 1: 1317–20
- Fisken R A, Heath D A, Somers S. Hypercalcaemia in hospital patients. Lancet 1981; 1: 202–7
- Mundy G R, Martin T J. Hypercalcemia of malignancy: Pathogenesis and management. Metabolism 1982; 31: 1247–77
- Posen S. Parathyroid and calcium disorders. Guide to the Diagnosis of Endocrine Disorders. Ne, R A Donald. Marcel Dekker, New York 1983; 465–503
- Llach F, Felsenfeld A J, Haussler M R. The pathophysiology of altered calcium metabolism in rhabdomyolysis-induced acute renal failure. N Engl J Med 1981; 305: 117–23
- Heath H, III, Hodgson S F, Kennedy M A. Primary hyperparathyroidism: Incidence, morbidity and potential economic impact on the community. N Engl J Med 1980; 302: 189–93
- Marx S J, Stock J L, Attie M. F., et al. Familial hypocalciuric hypercalcemia: Recognition among patients referred after unsuccessful parathyroid exploration. Ann Int Med 1980; 92: 351–6
- Payne R B, Carver M E, Morgan D B. Interpretation of serum total calcium: Effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in the individual. J Clin Pathol 1979; 32: 56–60
- Watson L, Moxham J, Fraser P. Hydrocortisone suppression test and discriminant analysis in differential diagnosis of hypercalcaemia. Lancet 1980; 1: 1320–5
- Posen S, Clifton-Bligh P, Mason R S. The management of primary hyperparathyroidism. Aust NZ J Med 1979; 9: 17–23
- Seshadri M S, Chan Y L, Wilkinson M. R., et al. An adenylate cyclase bioassay for parathyroid hormone: Some clinical experiences. Clin Sci 1985; 68: 321–6
- Stewart A F, Horst R, Deftos L. J., et al. Biochemical evaluation of patients with cancer-associated hypercalcemia. N Engl J Med 1980; 303: 1377–83
- Mundy G R, Wilkinson R, Heath D A. Comparative study of available medical therapy for hypercalcemia of malignancy. Am J Med 1983; 74: 421–32
- Mason R S, Frankel T L, Chan Y. L., et al. Vitamin D conversion by sarcoid lymph node homogenate. Ann Int Med 1984; 100: 59–61
- Mason R S, Posen S. The relevance of 25-hydroxycalciferol measurements in the treatment of hypoparathyroidism. Clin Endocrinol 1979; 10: 265–9
- Mason R S, Lissner D, Posen S, Norman A W. Blood concentrations of dihydroxylated vitamin D metabolites after an oral dose. Br Med J 1980; 1: 449–50
- Breslau N A, McGuire J L, Zerwekh J. E., et al. Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma. Ann Int Med 1984; 100: 1–7
- Shane E, Bilezikian J P. Parathyroid carcinoma: A review of 62 patients. Endocr Rev 1982; 3: 218–26